June 1, 2018
British Columbia Securities Commission
Alberta Securities Commission
The Manitoba Securities Commission
Ontario Securities Commission
Nova Scotia Securities Commission
Via Sedar
NOTICE PURSUANT TO SUBSECTION 11.3 OF
NATIONAL INSTRUMENT 51-102 (“NI 51-102”)
CONTINUOUS DISCLOSURE OBLIGATIONS
Pursuant to the requirements set out in subsection 11.3 of NI 51-102, the undersigned hereby gives notice of the results of voting from the June 1, 2018 Annual and Special Meeting (the “Meeting”) of shareholders of Trillium Therapeutics Inc. (the “Corporation”).
1. Election of Directors
The shareholders of the Corporation voted by ballot to elect the following individuals as directors of the Corporation until the next annual meeting of shareholders or until their successors are elected or appointed, as follows:
Name | Votes in Favour | % Votes in Favour | Votes Withheld | % Votes Withheld |
Mr. Luke Beshar | 5,071,936 | 98.89 | 56,904 | 1.11 |
Dr. Robert Kirkman | 5,071,906 | 98.89 | 56,934 | 1.11 |
Dr. Michael Moore | 5,072,821 | 98.91 | 56,019 | 1.09 |
Dr. Thomas Reynolds | 5,071,906 | 98.89 | 56,934 | 1.11 |
Dr. Niclas Stiernholm | 5,072,479 | 98.90 | 56,361 | 1.10 |
Dr. Calvin Stiller | 5,073,051 | 98.91 | 55,789 | 1.09 |
Dr. Helen Tayton-Martin | 5,073,252 | 98.92 | 55,588 | 1.08 |
2. Appointment of Auditors
The shareholders of the Corporation voted, on a show of hands, to reappoint Ernst & Young LLP, Chartered Professional Accountants, Licensed Public Accountants as auditors of the Corporation for the ensuing year and authorize the directors to fix their remuneration.
3. Approval of 2018 Stock Option Plan
The shareholders of the Corporation voted by ballot to approve the Corporation’s amended and restated stock option plan, all as more particularly set out in the management information circular prepared by the Corporation in respect of the Meeting. The voting results were as follows:
Votes in Favour | % Votes in Favour | Votes Against | % Votes Against |
3,897,219 | 76.81 | 1,176,621 | 23.19 |